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A B S T R A C T
Purpose and methods: The treatment of women with epilepsy during pregnancy is known to increase the
risk of teratogenic effects. Whether seizures during pregnancy have a deleterious effect on the
developing child is difﬁcult to determine, but recent animal studies, case studies, cohort studies and
population studies have provided useful insights.
Results and conclusion: Seizures before pregnancy are a predictor for seizures during pregnancy, and
catamenial epilepsy may also predict the course of seizures during pregnancy. A ﬁrst epileptic seizure
may also have implications for the pregnancy, depending on the seizure aetiology.
Seizures affecting maternal awareness and responsiveness may have cardiac effects on the foetus and
may impact on the weight of the newborn. Status epilepticus in pregnancy is rare, but isolated cases of
perinatal death and malformations after status epilepticus have been reported in women on antiepileptic
drugs. Seizures during delivery occur in about 2% of pregnancies of women with epilepsy, and case studies
indicate that the foetal heart may be affected. However, a diagnosis of epilepsy is not an indication per se for
caesarean delivery. A well-planned pregnancy can reduce the likelihood of seizures occurring.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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The threat of seizures during pregnancy and the consequences
that they might have on the developing foetus are fundamental
reasons for the prescription of daily antiepileptic medication (AED)
to a pregnant woman with epilepsy (WWE). As the pregnancy
nears its end, questions and concerns related to the delivery will
increase; are seizures likely during delivery and what are their
possible impacts?
However, it is obvious that obtaining clear evidence on the
effects of maternal seizures and AED treatment on a developing
foetus is fraught and difﬁcult. In this article we review and discuss
the currently available evidence on the potential impact of seizures
in pregnancy and delivery; this is the information upon which we,
as clinicians, must use as the basis of our patient treatment and
management decisions.
2. A ﬁrst seizure during pregnancy
The focus of this article is WWE. However, in the clinical setting,
the occurrence of a ﬁrst seizure during pregnancy may have many* Corresponding author at: Department of Neurology, Oslo University Hospital,
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woman. In the ﬁrst trimester, metabolic alterations, medications,
and toxicology screens should be evaluated. In the second
trimester, normal pregnancy-related physiological changes can
result in lower blood pressure and dilatation of vascular spaces,
and therefore syncopal events are a primary consideration. In the
third trimester, diagnoses such as eclampsia, posterior reversible
encephalopathy syndrome (PRES), and stroke are further possibili-
ties. Mass lesions, infections, and sudden events from vascular
malformations can occur at any time in pregnancy, and, given the
clinical situation, appropriate imaging should be performed.
3. Impact of seizures in women with epilepsy
In the EURAP study, a prospective observational study from 42
countries [1], 3784 pregnant WWE were monitored throughout
the entire course of their pregnancies and 66.6% of them were
found to be seizure-free. The proportion of pregnancies without
seizures was signiﬁcantly lower in lamotrigine (LTG)-treated
women (58.2%) than in pregnancies in women taking valproate
(VPA) (75%), carbamazepine (CBZ) (67.35%), or phenobarbital
(PHB) (73.4%). In addition, the LTG cohort also had signiﬁcantly
more generalized tonic clonic seizures (21.1%) than the VPA
(11.5%), CBZ (12.6%), or PB (14.0%) cohort.
In a hospital-based retrospective study of 205 women, Borthen
and coworkers [2] also found that the women with active epilepsyserved.
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were not increased in the group with epilepsy and no AED
treatment.
In a prospective study of 1297 pregnancies in WWE, Thomas
and coworkers [3] found that, as in the EURAP study, the
occurrence of seizures before pregnancy was the most important
predictor of seizures during pregnancy. The women who experi-
enced seizures in the pre-pregnancy month had a 15-times greater
risk of seizures during pregnancy, and polytherapy also increased
the risk of seizures during pregnancy; however, 47.5% of the WWE
were seizure-free. The lower rate of seizure freedom in this study,
compared with that reported in the EURAP study, may be due to
the inclusion of WWE without AED and also the dose of drugs being
relatively low. This study identiﬁed two peaks of seizure relapse (in
the second to third month and in the sixth month), and also that
those with generalized seizures had one peak during the ﬁrst
trimester.
A recently published retrospective cohort study evaluated the
effect of pregnancy planning in WWE on seizure control during
pregnancy and on maternal and neonatal outcomes [4]. Planned
pregnancies had a signiﬁcantly greater portion of patients
receiving AED monotherapy and of not using VPA. This group
also had a lower frequency of seizures during pregnancy as well as
a signiﬁcantly lower likelihood of altering their AED regime during
pregnancy.
The impact of a speciﬁc pattern of seizures before pregnancy on
the course during pregnancy has been recently investigated in a
prospective follow-up of seizure course in women with catamenial
epilepsy and women with noncatamenial epilepsy [5]. Seizure
control was improved during pregnancy in the catamenial group,
with 44.1% of the participants experiencing a reduction in seizures
of 50%, whereas only 6.5% of those with noncatamenial epilepsy
had a similar reduction in seizures.
3.1. Impact of focal seizures
The relative impacts of different seizure types are difﬁcult to
determine. A developing foetus in a mother’s womb is not
readily accessible for scientiﬁc studies, and therefore the
immediate risk from a seizure is difﬁcult to measure. Although
these obstacles have hindered research, particularly on the effect
of focal seizures where consciousness is not affected, it is
generally accepted that these types of focal seizures have
minimal effect on the foetus. However, in focal seizures where
awareness and responsiveness are affected, trauma may occur.
Case reports have also indicated that the developing child
may be affected when the mother experiences a seizure of
this type.
Although it is not easy to determine the status of a foetus during
an attack that lasts only a couple of minutes, there are two reports
in the literature on the effects on the foetus during focal seizures
where maternal awareness was affected. Nei and coworkers [6]
report on a woman with a history of febrile seizures who had
experienced complex partial seizure (CPS) since the age of ﬁve
years, beginning with automatisms and followed by 1–2 min of
reduced consciousness. Her history also included some generalized
tonic-clonic seizures (GTCS) and she experienced between 1 and
5 CPS per month during the pregnancy. At week 39 of the
pregnancy, the estimated foetal weight was below the tenth
percentile. At week 42 of the pregnancy, while having uterine
contractions every 2–3 min, the woman suddenly sat upright, was
unable to respond, had agitated eye deviation, showed repeating
head nodding for 1 min, and was confused for 5 min. During this
period she had a prolonged uterine contraction, with no return to
baseline for 4 min, and the foetal heart rate fell from 140 to 78
beats per minute.The other report, by Sahoo and Klein [7], refers to a patient who
experienced partial seizures secondary to cavernous haemangio-
mas and had CPS, of which three had been secondary GTCS.
During pregnancy, the patient’s seizure frequency decreased to
0.25 per month during the ﬁrst half of the pregnancy. She was
admitted in her 7th month of pregnancy following two CPS and
experienced a further CPS directly after admission, with right
facial twitching and subsequent right arm and leg twitching. The
patient was pale and sweating, and transiently hypoxic (75%). The
seizure lasted 1 min. During the seizure, the foetal heart rate fell
from 160 to 70 beats per minute, and returned to baseline 2 min
after the seizure.
Importantly, for both cases, the patients delivered apparently
healthy children.
3.2. Impact of generalized seizures
Generalized seizures are feared the most. In addition to the
possibility of trauma, GTCS are also known to cause alterations in
electrolytes, blood pressure, and oxygenation, all of which may
harm the foetus [8]. Furthermore, the immature brain is very
sensitive to abnormal experiences [9].
Most studies in pregnant WWE have been conducted while the
women were using AED and this adds the complication of AED as a
confounding variable. Animal studies may avoid this problem for
investigating the effect of seizures per se on the foetus.
Antenatal hypoxia-ischaemia has been found to represent a risk
factor for functional alterations of the brain structures and
functions related to anxiety and fear [9]. Rat foetuses that were
exposed to an intermittent hypoxia antenatally exhibited less
motor activity and increased levels of anxiety [10]. The speciﬁc
effects of seizures on the foetuses of rats have been studied in
greater detail more recently. Vale and coworkers [11] used a
pilocarpine-induced epilepsy model, and found a signiﬁcant effect
on speciﬁc hippocampal interneurons in the pups of mothers with
epileptic seizures during pregnancy. The same animal model also
demonstrated that the offspring of the epileptic mothers had
deﬁcits in motor coordination and increased immobility [12]. The
placentas from the epileptic rat models had areas of ischaemic
infarction. More recently, rats exposed to seizures in utero showed
impaired social behaviour compared with rats with no intrauterine
exposure to seizures [13].
In humans, some idea on the potential impact of GTCS on the
developing foetus can be extrapolated from studies in eclampsia
[14], where changes in foetal heart rate occur during convulsions.
In WWE, only a few case studies have demonstrated a speciﬁc
effect on the foetus after GTCS; two cases were described by
Teramo and coworkers in 1979 [15]. The ﬁrst foetus exhibited a 13-
min continuous bradycardia tachycardia immediately after the
seizure, and this was followed by a phase of tachycardia. The other
foetus had a shorter period of bradycardia, followed by tachycardia
and decreased heart rate. Intracranial haemorrhage in utero,
resulting in foetal death after a maternal seizure, has also been
reported [16]. A study of 106 pregnant WWE on AED therapy and
experiencing more than one GTCS during pregnancy reported a
signiﬁcant association, with an overall ﬁve-times higher preterm
risk, a shorter gestational age, and a reduced birth weight in
boys [17].
Concerns have been raised regarding cognitive deﬁciencies in
children born to mothers using AED [18]. Studies on 67 children
born to mothers with epilepsy, of whom 13 did not use any AED,
did not ﬁnd any neuropsychological effects on the non-exposed
children [19,20]. Nevertheless, there are indications that seizures
in pregnancy may have an impact on the children’s neurodevelop-
ment. In a study by Cummings and coworkers on the neurode-
velopment of children exposed to AED in utero, univariable analysis
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and detrimental effect on neurodevelopment [21].
A study by Adab and coworkers was one of the ﬁrst to associate
a developmental risk with the occurrence of seizures during
pregnancy [22]. By investigating 240 children above the age of six
years, of whom 80 children had mothers with epilepsy who did not
use any AEDs during pregnancy, they found three factors that were
independently predictive of a low IQ. In addition to VPA therapy
and lower maternal IQ, they found that ﬁve or more GTCS during
pregnancy was an independent factor for low IQ.
As previously noted, an important problem in discerning the
impact of seizures on the foetus is the potential confounding factor
concerning the use of AED. A study by Chen and coworkers [23] is
extraordinary in this respect; in this study, two nationwide
population-based data sets compared 1016 untreated WWE with
8128 matched women without chronic disease. The epilepsy was
documented by a diagnosis of epilepsy or convulsions and further
conﬁrmed by at least three consensus diagnoses during the
two year-period prior to the delivery. Almost 50% of the WWE
experienced seizures during pregnancy. The study found a clear
association with the occurrence of seizures during pregnancy and
the child being small for gestational age, and also that seizures
during pregnancy were more likely to be associated with preterm
delivery and lower birth weight.
Status epilepticus (SE) was reported in 21 (0.6%) of the 3784
pregnancies reported in the EURAP study [1], of these, ten were
convulsive, and all cases were evenly distributed over the three
trimesters. Perinatal death occurred in one of the women
experiencing a convulsive SE and major congenital malformations
were diagnosed in three children born to mothers who developed
SE during the pregnancy. None of the mothers died.
4. Increased mortality in pregnant WWE?
From the maternal death registry in United Kingdom, Adab and
coworkers [22] found that the odds for maternal death were 10-
times higher for WWE than in the general population. They also
noted that this seemed to represent an increased mortality risk
during pregnancy, that is above the usual standard mortality rate
of 2–3 for epilepsy throughout life as a whole, and also that the case
histories in the reports suggested that seizure occurrence was
often associated with stopping AED or with poor compliance. The
question regarding increased mortality risk in WWE during
pregnancy was recently explored [24], based on data in the
successor to this registry, where all maternal deaths and their
circumstances are reported in detail. Among 2,291,493 materni-
ties, WWE accounted for fourteen deaths, among which SUDEP
was diagnosed in 11 (79%). Of the remaining three deaths, one
occurred while bathing, one was due to hypoxic brain damage, and
the last was due to chest trauma with secondary sepsis following a
seizure. Nine deaths occurred during pregnancy and ﬁve were
postpartum. Nine deaths occurred in women treated with LTG,
seven of whom used LTG in monotherapy. The epilepsy-related
deaths in pregnant women were found to be relatively constant
over the last 15 years, ranging from nine (between 1991 and 1993)
to 19 (between 1994 and 1996) per year.
Maternal death from epilepsy in WWE was estimated to be
100 per 100,000, as compared with the overall mortality of 11 per
100,000. From these data it was estimated that the death rate from
epilepsy among WWE during or shortly after pregnancy is 1:1000,
which is ten times higher than in women without epilepsy. The
study also pointed out that a general population-based study of
SUDEP estimated an incidence of 0.35%, with much higher rates in
intractable patient groups. It may be speculated that most WWE
who become pregnant are less likely to have the most severe types
epilepsy or serious comorbidities, and from this it may beextrapolated that the data suggest a particular risk associated
with being pregnant for WWE. However, the SUDEP rate in the
general population may not necessarily be applicable to women of
fertile age; two recently published papers show that the SUDEP
rate in younger epilepsy patients is closer to 10-times that of the
general population, whereas the SUDEP rate in the general epilepsy
population is estimated to be 2–3 times that of the general
population [25,26].
5. Delivery
WWE have an increased risk of delivery complications, but the
seizures per se do not explain this increased risk [2]. Cardiac effects
on the child arising during a maternal seizure during labour and
delivery have been reported in case studies as previously discussed
[6,15]. In a rat study, in which the confounding effects of AEDs are
avoided, perinatal asphyxia of 20 min resulted in a behavioural
pattern resembling the hyperactive proﬁle in ADHD children [27].
Seizures during delivery are, however, rare. In the EURAP study,
seizures during delivery occurred in 2.6% of pregnancies in WWE
on LTG and CBZ, in 1.9% in those using PHB, and in 1.4% of women
exposed to VPA. The Kerala Registry of Epilepsy and Pregnancy [3]
found that seizure relapse was highest during the three peripartum
days, noting again that this study comprised women not on AED
and many on relatively low doses of AED. This underlines a
practical point during delivery for WWE; they should bring their
own AEDs to the delivery and the medication should be taken at
the usual times during labour.
Epilepsy is not considered as a reason for caesarean delivery,
unless a seizure occurs during labour or the patient is unable to
cooperate [28]. Reassurance and well-informed health care
professionals in the delivery room is of importance for these
patients.
6. Conclusion
Case studies have demonstrated that seizures may have an
impact on the foetal heart during pregnancy and delivery, and a
study of non-treated WWE demonstrated that seizures could also
affect the size of the child. Recent studies have also indicated that
seizures in pregnancy may be of importance for cognition. Status
epilepticus is rare, but there are occasional reports of foetal deaths
and malformations after SE in AED-treated women. Animal studies
indicate that there can be speciﬁc effects of seizures on
neurodevelopment. Whether pregnant WWE have increased
mortality is not clear. Seizures at delivery are rare, and epilepsy
is not, in itself, an indication for caesarean delivery. The frequency
of seizures in pregnancy may be signiﬁcantly reduced in women
with catamenial epilepsy, and the risk of seizures during
pregnancy may be decreased by careful planning.
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